Erratum: Peripheral Frequency of CD4+ CD28− Cells in Acute Ischemic Stroke: Relationship with Stroke Subtype and Severity Markers (Medicine 94:20 (e813) DOI: 10.1097/MD.0000000000000813);Peripheral frequency of CD4+ CD28-cells in acute ischemic stroke relationship with stroke subtype and severity markers

Medicine (United States)

Volumn 94, Issue 20, 2015, Pages

  Tuttolomondo, Antonino ^a   Pecoraro, Rosaria ^a,c   Casuccio, Alessandra ^a   Di Raimondo, Domenico ^a,b,d   Buttà, Carmelo ^a   Clemente, Giuseppe ^a   Della Corte, Vittoriano ^a   Guggino, Giuliana ^d   Arnao, Valentina ^a   Maida, Carlo ^a   Simonetta, Irene ^a   Maugeri, Rosario ^a   Squatrito, Rosario ^c   Pinto, Antonio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Fondazione Istituto San Raffaele G Giglio   (Italy)

^d Divisione Medicina Interna e Specialistica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CD28+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; NULL CELL; PRIORITY JOURNAL; T LYMPHOCYTE; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CEREBROVASCULAR ACCIDENT; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; PATHOLOGY; RISK; SEVERITY OF ILLNESS INDEX;

CD28 ANTIGEN;

AGED; ANTIGENS, CD28; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE SUBSETS; RISK; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84937965362     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/01.md.0000466908.35208.7e     Document Type: Erratum

References (43)

1. Morishita Y, Martin PJ, Bean MA, et al. Antigen-specific functions of a CD4+ subset of human T lymphocytes with granular morphology. J Immunol. 1986;136:2095-2102.
2. Vallejo AN, Nestel AR, Schirmer M, et al. Aging-related deficiency of CD28 expression in CD4+ T cells is associated with the loss of gene-specific nuclear factor binding activity. J Biol Chem. 1998;273:8119-8122.
3. Vallejo AN, Brandes JC, Weyand CM, et al. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol. 1999;162:6572.
4. Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135-2139.
5. Zal B, Kaski JC, Akiyu JP, et al. Differential pathways govern CD4+ CD28-T cell proinflammatory and effector responses in patients with coronary artery disease. J Immunol. 2008;181:5233-5241.
6. Rong Jin, Guojun Y, Guohong L. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010;87:779-789.
7. Liuzzo G, Biasucci LM, Trotta G, et al. Unusual CD4+ CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol. 2007;50:1450-1458.
8. Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883-2888.
9. Nadareishvili ZG, Li H, Wright V, et al. Elevated pro-inflammatory CD4+ CD28-lymphocytes and stroke recurrence and death. Neurology. 2004;63:1446-1451.
10. Nowik M, Nowacki P, Grabarek J, et al. Can we talk about CD4+ CD28-lymphocytes as a risk factor for ischemic stroke? Eur Neurol. 2007;58:26-33.
11. Hatano S. Experience from a multicenter Stroke register; a preliminary report. Bull World Health Organ. 1976;54:541.
12. Licata G, Tuttolomondo A, Corrao S, et al. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Int J Immunopathol Pharmacol. 2006;19:639-644.
13. Pinto A, Tuttolomondo A, Di Raimondo D, et al. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. Int Angiol. 2006;25:261-267.
14. Tuttolomondo A, Di Raimondo D, Di Sciacca R, Casuccio A, et al. Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis. 2010;208:290-296.
15. Tuttolomondo A, Di Raimondo D, Forte GI, et al. Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine. 2012;58:398-405.
16. Nilupul PM, Ma HK, Arakawa S, et al. Inflammation following stroke. J Clin Neurosci. 2006;13:1-8.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-44.
18. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
19. Lyden P, Shuaib A, Ng K, et al., CLASS-I/H/T Investigators. Clomethiazole acute stroke study in ischemic stroke (CLASS-I): final results. Stroke. 2002;33:122-128.
20. Rankin J. Cerebral vascular accidents in patients over the age of 60: prognosis. Scott Med J. 1957;2:200-215.
21. Del Zoppo G, Ginis I, Hallenbeck JM, et al. Inflammation and stroke: putative role for cytokines, adhesion molecules and i-NOS in brain response to ischemia. Brain Pathol. 2000;10:95.
22. Ferrarese C, Mascarucci P, Zoia C, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab. 1999;19:1004-1009.
23. Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Immuneinflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis. 2010;213:311-318.
24. Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Inflammation in ischemic stroke subtypes. Curr Pharm Des. 2012;18:4289-4310.
25. Pinto A, Tuttolomondo A, Casuccio A, et al. Immunoinflammatory predictors of stroke at follow-up in patients with chronic nonvalvular atrial fibrillation. Clin Sci. 2009;116:781-789.
26. Tuttolomondo A, Di Sciacca R, Di Raimondo D, et al. Plasma levels of inflammatory and thrombotic-fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct size. J Neuroimmunol. 2009;2015:84-89.
27. Arumugam TV, Granger DN, Mattson MP. Stroke and T-cells. Neuromol Med. 2005;7:229-242.
28. Schroeter M, Jander S, Witte OW, et al. Local immune responses in the rat cerebral cortex aftermiddle cerebral artery occlusion. J Neuroimmunol. 1994;55:195-203.
29. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
30. Crocker SJ, Pagenstecher A, Campbell IL. The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res. 2004;75:1-11.
31. Liesz A, Zhou W, Mracskó É, et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134:704-720.
32. Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia. 2005;50:329-339.
33. Lou J, Gasche Y, Gasche Y, et al. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. Lab Invest. 1999;79:1015-1025.
34. Hug A, Dalpke A, Wieczorek N, et al. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke. 2009;40:3226-3232.
35. Klehmet J, Harms H, Richter M, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience. 2009;158:1184-1193.
36. Offner H, Vandenbark AA. Hurn PDEffect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience. 2009;158:1098-1111.
37. Gendron A, Teitelbaum J, Cossette C, et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res. 2002;955:85-97.
38. Prass K, Meisel C, Höflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;98:725-736.
39. Waase I, Kayser C, Carlson PJ, et al. Oligoclonal T cell proliferation in patients with rheumatoid arthritis and their unaffected siblings. Arthritis Rheum. 1996;39:904.
40. Park W, Weyand CM, Schmidt D, et al. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD41CD282 T cells. Eur J Immunol. 1997;27:1082.
41. Schirmer M, Vallejo AN, Weyand CM, et al. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD41CD282; T cells from rheumatoid arthritis patients. J Immunol. 1998;161:1018.
42. Strano A, Hoppensteadt D, Walenga JM, et al. Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial disease. Semin Thromb Hemost. 1996;22:35-40.
43. Crepaldi G, Fellin R, Calabrò A, et al. Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use. Atherosclerosis. 1990;81:233-243.